2m 2m 2m 2m 2m 2m 2m
BETA BIONICS (BBNX)
NASDAQ
$16.00-$0.57 (-3.43%)
Price as of Sep 11, 2026 8:00 PM EDT- $745.5MMarket Cap
- -37.26%1-Year Change
- Medical DevicesIndustry
BETA BIONICS (BBNX)
$16.00-$0.57 (-3.43%)
BBNX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $16.57 | ||
Change | -$0.02 (-0.12%) | ||
Open | $16.59 | ||
High | $16.71 | ||
Low | $15.85 | ||
Previous Close | $16.59 | ||
Volume | 726,146 | ||
30-Day Average Volume | 1,068,339 | ||
1-Week Change | -14.68% | ||
1-Month Change | -5.96% | ||
1-Year Change | -37.26% | ||
3-Year Change | N/A | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 45.0M | ||
Total Assets | $292.4M | ||
Market Cap | $745.5M | ||
Enterprise Value | $701.2M | ||
Period: QTR TTM FY | |||
Revenue | $32.0M | ||
Net Income | -$23.4M | ||
Free Cash Flow | -$15.7M | ||
EBIT | -$23.4M | ||
EBITDA | -$22.7M | ||
Net Working Capital | $205.0M | ||
EPS | -$0.53 | ||
Enterprise Value/EBITDA | -31 | ||
Enterprise Value/Revenue | 22 | ||
P/B | 3 | ||
P/E | -31 | ||
PEG | 4 | ||
Price/Free Cash Flow | -48 | ||
Price/Operating Cash Flow | -51 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue